Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTMPE for CAV detection in heart transplant recipients
NCT02880137Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren lipid microspheres in cardiac allograft vasculopathy (CAV), sponsored by Mayo Clinic. Started Sep 2016; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
cardiac allograft vasculopathy (CAV)
Beyond the preview
Go deeper on NCT02880137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880137.